Research Associate
Laboratory for Molecular Biology (LMB)

Institute of molecular genetics and genetic engineering (IMGGE),
University of Belgrade (UB)

V. Stepe 444a, P.Fah 23, 11010 Belgrade, Serbia
Mobile:  +381 65 397 66 58                                   
Phone:  +381 11 397 66 58
Fax:      +381 11 397 58 08
E-mail: marijast@imgge.bg.ac.rs

EDUCATION

2010 - PhD in Molecular Biology, Faculty of Biology (FB), UB (THESIS: Analysis of gene variants in chronic obstructive pulmonary disease in humans)

2003 - BSc in Molecular Biology and Physiology, FB, University of Belgrade

RESEARCH EXPERIENCE

2011 - Research Associate Laboratory for Molecular Biology, IMGGE

2007 - 2011 - Research Assistant LMB,IMGGE

2004 - 2007 - Research TraineeLMB, IMGGE

2003 - 2004 - postgraduate schoolarship by the Ministry of Science and Environmental Protestion, Republic of Serbia

CAREER HISTORY

2013 - 2015 - Postdoc Fellow, Feinberg graduate school, Weizmann Institute of Science, Rehovot, Israel

2011 - 2012 - assistant coordinator of the project: Complex diseases as a model system for phenotype modulation - structural and functional analysis of molecular biomarkers -  Pulmonary phenotype, MESTDS, 173008

2011 – 2011 - Lecturer on PhD programme in Molecular Biology, Faculty of Biology, University of Belgrade, Subject: Molecular genetic in the diagnostic, prevention and therapy of human diseases

2013 - Reviewer in American Journal of Biomedical Research

2012 - membership Oxygen Club of California

2004 - membership European Respiratory Society

RESEARCH INTEREST

- respiratory disorders: COPD, bronchiectasis, asthma, etiopathology of emphisematous and fibrotic lesions, inflammation and oxidative stress of the lungs

- approaches: genetic association studies, gene expressions, gene-environment interactions, phenotype modulation, biomarkers

SELECTED PUBLICATIONS

1. Polymorphisms of beta2-adrenergic receptor gene in Serbian asthmatic adults: effects on response to beta-agonists. Petrovic-Stanojevic N,Topic A, Nikolic A,Stankovic M, Dopudja-Pantic V,Milenkovic B,Radojkovic D.Mol Diagn Ther.2014 Jul 30. Epub ahead of print.

http://www.ncbi.nlm.nih.gov/pubmed/25074500

2. Gender-related reference intervals of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine determined by liquid chromatography-tandem mass spectrometry in Serbian population. Topic A, Francuski D, Markovic B, Stankovic M, Dobrivojevic S, Drca S, Radojkovic D. Clin Biochem. 2013;46(4-5):321-6.

http://www.ncbi.nlm.nih.gov/pubmed/23261837

3. Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases. Topic A, Stankovic M, Divac-Rankov A, Petrovic-Stanojevic N, Mitic-Milikic M, Radojkovic D. Genet Test Mol Biomarkers. 2012;16(11):1282-6.

http://www.ncbi.nlm.nih.gov/pubmed/22971141

4. Therapeutic Potential of NO-Modified Drugs in Colon Cancer Cells. Mojic M, Mijatovic S, Maksimovic-Ivanic D, Miljkovic D, Stosic-Grujicic S, Stankovic M, Mangano K, Travali S, Donia M, Fagone P, Zocca MB, Al-Abed Y, McCubrey JA, Nicoletti F. Mol Pharmacol. 2012;82(4):700-10.

http://www.ncbi.nlm.nih.gov/pubmed/22798453

5. Prothrombotic genetic risk factors in stroke: a possible different role in pediatric and adult patients. Djordjevic V, Stankovic M, Brankovic-Sreckovic V, RakicevicLj, Damnjanovic T, Antonijevic N, Radojkovic D. Clin Appl Thromb Hemost. 2012;18(6):658-61.

http://www.ncbi.nlm.nih.gov/pubmed/22275392

6. A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein.Kojic S, Nestorovic A, Rakicevic L, Belgrano A, Stankovic M, Divac A, Faulkner G. Arch Biochem Biophys. 2010;502(1):60-7.

http://www.ncbi.nlm.nih.gov/pubmed/20599664

7. TNF-α-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Stankovic M, Nestorovic A, Tomovic A, Petrovic-Stanojevic N, Andjelic-Jelic M, Dopudja-Pantic V, Nagorni-Obradovic Lj, Mitic-Milikic M, Radojkovic D. Neoplasma. 2009;56(4):348-52.

http://www.ncbi.nlm.nih.gov/pubmed/19469656

8. Matrix metalloproteinases gene variants in idiopathic disseminated bronchiectasis. Stankovic M, Nikolic A, Divac A, Rakicevic Lj, Tomovic A, Mitic-Milikic M, Nagorni-Obradovic Lj, Grujic M,Petrovic-Stanojevic N, Andjelic-Jelic M, Dopudja-Pantic V, Radojkovic D. J Investig Med. 2009;57(3):500-503.

http://www.ncbi.nlm.nih.gov/pubmed/19188843

9. Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay? Djordjevic V, Stankovic M, Brankovic-Sreckovic V, RakicevicLj, Radojkovic D. J Child Neurol. 2009;24(7):823-7.

http://www.ncbi.nlm.nih.gov/pubmed/19372095

10. The CFTR M470V gene variant as a potential modifier of COPD severity: study of Serbian population. Stankovic M,Nikolic A,Divac A,Tomovic A,Petrovic-Stanojevic N,Andjelic M,Dopudja-Pantic V,Surlan M,Vujicic I,Ponomarev D,Mitic-Milikic M,Kusic J, Radojkovic D. Genet Test. 2008;12(3):357.

http://www.ncbi.nlm.nih.gov/pubmed/18652532

11. PCR amplification on whole blood samples treated with different commonly used anticoagulants. Djordjevic V, Stankovic M, Nikolic A, Antonijevic N, Rakicevic Lj, Divac A, Radojkovic M. Pediatr Hematol Oncol. 2006;23:517.

http://www.ncbi.nlm.nih.gov/pubmed/16849283

12. Analysis of common CFTR polymorphisms 5T, M470V and R75Q in healthy Serbian population. Nikolic A, Divac A, Stankovic M, Dinic J, Tomic B, Ljujic M. Russ J Genet. 2006;42(7):821.

http://www.ncbi.nlm.nih.gov/pubmed/16915933

13. Indirect diagnosis of haemophilia B by multiplex PCR/RFLP. Stankovic M, Rakicevic L, Mikovic D, Jankovic G, Nikolic A. Clin Lab Haematol. 2005;27(2):145.

http://www.ncbi.nlm.nih.gov/pubmed/15784132